Kimberly Gentile - Jan 2, 2024 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
SVP, Clinical Operations
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 08:07 PM
Previous filing
Nov 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +96.3K $0.00 96.3K Jan 2, 2024 Common Shares 96.3K $41.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in four equal installments on January 2, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service with the Issuer at each vesting date.